Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

5.38
Delayed Data
As of 10:06am ET
 -0.1453 / -2.63%
Today’s Change
4.76
Today|||52-Week Range
8.24
-9.58%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close5.53
Today’s open5.51
Day’s range5.38 - 5.51
Volume1,863
Average volume (3 months)4,660
Market cap$26.8M
Dividend yield--
Data as of 10:06am ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio44.8
Price/Sales2.70
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
DRIODarioHealth Corp-0.01-0.34%
KDUSCadus Corp0.000.00%
BNTCBenitec Biopharma Lt...-0.11-4.17%
CSBRChampions Oncology I...+0.01+0.38%
Data as of 11:11am ET, 04/27/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts


Search for Jobs